1. CD8 chemokine receptors in chronic obstructive pulmonary disease.
- Author
-
Smyth, L. J. C., Starkey, C., Gordon, F. S., Vestbo, J., and Singh, D.
- Subjects
OBSTRUCTIVE lung diseases ,BRONCHOALVEOLAR lavage ,LUNG disease diagnosis ,CIGARETTE smoke ,CD antigens ,CHEMOKINES ,LIGANDS (Biochemistry) - Abstract
Increased lung CD8 cells and their expression of chemokine receptors CXCR3 and CCR5 have been previously reported in chronic obstructive pulmonary disease (COPD). Alterations of CD8-CCR3 and -CCR4 expression and their ligands in COPD patients have not been fully investigated. The objective of this study was to assess in COPD patients: (i) broncho-alveolar lavage (BAL) CD8 CCR3 and CCR4 expression in COPD patients; and (ii) airway levels of the CCR3 ligands, CCL11 and CCL5. Multi-parameter flow cytometric anlaysis was used to assess BAL CD3 and CD8-chemokine receptor expression in COPD patients, smokers and healthy non-smokers (HNS). CCL5 and CCL11 levels were measured in BAL, and from the supernatants of lung resection explant cultures. CD8-CCR3 and -CCR5 expression (means) were increased in COPD patients (22% and 46% respectively) and smokers (20% and 45%) compared with HNS (3% and 22%); P < 0·05 for all comparisons. CD3CXCR3 expression was raised in smokers and COPD while CD8CXCR3 and CD3 and CD8 CCR4 expression was similar between groups. CD8CCR5 expression correlated to smoking pack years ( r = 0·42, P = 0·01). COPD explants released more CCL5 compared with smokers ( P = 0·02), while there was low level CCL11 production. CD8CCR3 and CCR5 expression appear to be regulated by cigarette smoke exposure. We show that COPD lung tissue released more CCL5, suggesting a role for CCL5–CCR3 signalling in pulmonary CD8 recruitment in COPD. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF